Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 12, Issue 20
15 October 2006
Issue Cover
All Issues
  • Cover Image

    Cover Image

    issue cover
    Estrogen stimulation of HSG salivary gland adenocarcinoma cells results in a profound cytoskeleton reorganization, including the appearance of cytoplasmic extensions like formation of lamellipodia, filopodia, and membrane spikes. Cells were cultured in the medium supplemented with 1% dextran charcoal-coated serum for 48 hours before stimulating with 10 nM of estrogen. Confocal scanning microscopy was done using fluorescent-phalloidin (for F-actin) and ToPro3 (for DNA). For further details, please see Ohshiro et al. on page 5994 in this issue.
  • PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265

Editorial

Can a Single Pill Replace Doublet Chemotherapy in First-Line Therapy of Advanced Non–Small Cell Lung Cancer?
Paul A. Bunn, Jr.
View articletitled, Can a Single Pill Replace Doublet Chemotherapy in First-Line Therapy of Advanced Non–Small Cell Lung Cancer?
Open the PDF for in another window

The Biology Behind

Natural Killer T Cell–Based Cancer Immunotherapy
Hans J.J. van der Vliet; Steven P. Balk; Mark A. Exley
View articletitled, Natural Killer T Cell–Based Cancer Immunotherapy
Open the PDF for in another window

Molecular Pathways

The Hedgehog Signaling Pathway in Cancer
Marie Evangelista; Hua Tian; Frederic J. de Sauvage
View articletitled, The Hedgehog Signaling Pathway in Cancer
Open the PDF for in another window

Special Article

The FLIP-Side of Fas Signaling
Marc L. Hyer; Temesgen Samuel; John C. Reed
View articletitled, The FLIP-Side of Fas Signaling
Open the PDF for in another window

Human Cancer Biology

PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia
Monica Prasad Hayes; Hong Wang; Rosanny Espinal-Witter; Wayne Douglas; Garron J. Solomon; Suzanne J. Baker; Lora Hedrick Ellenson
View articletitled, <em>PIK3CA</em> and <em>PTEN</em> Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia
Open the PDF for in another window
Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma
Mark R. Anderson; Rebecca Harrison; Paul A. Atherfold; Moray J. Campbell; S. Jane Darnton; Jolanta Obszynska; Janusz A.Z Jankowski
View articletitled, Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma
Open the PDF for in another window
Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma
Ben Davidson; Zhen Zhang; Lilach Kleinberg; Mei Li; Vivi Ann Flørenes; Tian-Li Wang; Ie-Ming Shih
View articletitled, Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma
Supplementary data
Open the PDF for in another window
GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1
Yu Wen; Sarah F. Giardina; David Hamming; Jennifer Greenman; Emmanuel Zachariah; Manny D. Bacolod; Hao Liu; Jinru Shia; Peter S. Amenta; Francis Barany; Phillip Paty; William Gerald; Daniel Notterman
View articletitled, GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1
Supplementary data
Open the PDF for in another window
Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma
Amy F. Ziober; Kirtesh R. Patel; Faizan Alawi; Phyllis Gimotty; Randall S. Weber; Michael M. Feldman; Ara A. Chalian; Gregory S. Weinstein; Jennifer Hunt; Barry L. Ziober
View articletitled, Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma
Supplementary data
Open the PDF for in another window
Carcinoembryonic Antigen Messenger RNA Expression in Blood Predicts Recurrence in Esophageal Cancer
Tetsuro Setoyama; Shoji Natsugoe; Hiroshi Okumura; Masataka Matsumoto; Yasuto Uchikado; Sumiya Ishigami; Tetsuhiro Owaki; Sonshin Takao; Takashi Aikou
View articletitled, Carcinoembryonic Antigen Messenger RNA Expression in Blood Predicts Recurrence in Esophageal Cancer
Open the PDF for in another window
The Potential of BORIS Detected in the Leukocytes of Breast Cancer Patients as an Early Marker of Tumorigenesis
Vivien D'Arcy; Ziedulla K. Abdullaev; Naresh Pore; France Docquier; Verónica Torrano; Igor Chernukhin; Melissa Smart; Dawn Farrar; Metodi Metodiev; Nelson Fernandez; Carlos Richard; M. Dolores Delgado; Victor Lobanenkov; Elena Klenova
View articletitled, The Potential of BORIS Detected in the Leukocytes of Breast Cancer Patients as an Early Marker of Tumorigenesis
Open the PDF for in another window
Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer
Llana Pootrakul; Ram H. Datar; Shan-Rong Shi; Jie Cai; Debra Hawes; Susan G. Groshen; Amy S. Lee; Richard J. Cote
View articletitled, Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer
Open the PDF for in another window
Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma Cells
Kazufumi Ohshiro; Suresh K. Rayala; Michelle D. Williams; Rakesh Kumar; Adel K. El-Naggar
View articletitled, Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma Cells
Open the PDF for in another window
The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer
Vidar Staalesen; Stian Knappskog; Ranjan Chrisanthar; Silje H. Nordgard; Erik Løkkevik; Gun Anker; Bjørn Østenstad; Steinar Lundgren; Terje Risberg; Ingvil Mjaaland; Inger Torhild Gram; Vessela N. Kristensen; Anne-Lise Børresen-Dale; Johan Richard Lillehaug; Per Eystein Lønning
View articletitled, The Novel <em>p21</em> Polymorphism <em>p21<sup>G251A</sup></em> Is Associated with Locally Advanced Breast Cancer
Open the PDF for in another window
A Homeobox Protein, Prox1, Is Involved in the Differentiation, Proliferation, and Prognosis in Hepatocellular Carcinoma
Masayuki Shimoda; Meiko Takahashi; Takanobu Yoshimoto; Tomoya Kono; Iwao Ikai; Hajime Kubo
View articletitled, A Homeobox Protein, Prox1, Is Involved in the Differentiation, Proliferation, and Prognosis in Hepatocellular Carcinoma
Open the PDF for in another window
Glucocorticoids Suppress Tumor Lymphangiogenesis of Prostate Cancer Cells
Akihiro Yano; Yasuhisa Fujii; Aki Iwai; Satoru Kawakami; Yukio Kageyama; Kazunori Kihara
View articletitled, Glucocorticoids Suppress Tumor Lymphangiogenesis of Prostate Cancer Cells
Open the PDF for in another window

Imaging, Diagnosis, Prognosis

Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy
Jonathan R. Reeves; Hélène Dulude; Chandra Panchal; Luc Daigneault; Dharam M. Ramnani
View articletitled, Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy
Open the PDF for in another window
Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma
Berthold Streubel; Daniela Huber; Stefan Wöhrer; Andreas Chott; Markus Raderer
View articletitled, Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma
Open the PDF for in another window
The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
Elena López-Knowles; Silvia Hernández; Manolis Kogevinas; Josep Lloreta; Alex Amorós; Adonina Tardón; Alfredo Carrato; Sirish Kishore; Consol Serra; Núria Malats; Francisco X. Real; on behalf of the EPICURO Study Investigators
View articletitled, The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
Supplementary data
Open the PDF for in another window
Functional Plasminogen Activator Inhibitor-1 Gene Variants and Breast Cancer Survival
Xianglan Zhang; Xiao-Ou Shu; Qiuyin Cai; ZhiXian Ruan; Yu-Tang Gao; Wei Zheng
View articletitled, Functional Plasminogen Activator Inhibitor-1 Gene Variants and Breast Cancer Survival
Open the PDF for in another window
Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer
Hirokazu Uyama; Yasuhiko Tomita; Hideji Nakamura; Shoji Nakamori; Binglin Zhang; Yoshihiko Hoshida; Hirayuki Enomoto; Yorihide Okuda; Masato Sakon; Katsuyuki Aozasa; Ichiro Kawase; Norio Hayashi; Morito Monden
View articletitled, Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer
Open the PDF for in another window

Cancer Therapy: Clinical

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study
Giuseppe Giaccone; Marielle Gallegos Ruiz; Thierry Le Chevalier; Nick Thatcher; Egbert Smit; Jose Antonio Rodriguez; Pasi Janne; Dalila Oulid-Aissa; Jean-Charles Soria
View articletitled, Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study
Open the PDF for in another window
Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients
Stephen M. Ansell; Susan M. Geyer; Matthew J. Maurer; Paul J. Kurtin; Ivana N.M. Micallef; Philip Stella; Paul Etzell; Anne J. Novak; Charles Erlichman; Thomas E. Witzig
View articletitled, Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients
Open the PDF for in another window
A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus
Bernard M. Tijink; Jan Buter; Remco de Bree; Giuseppe Giaccone; Margreet S. Lang; Alexander Staab; C. René Leemans; Guus A.M.S. van Dongen
View articletitled, A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus
Open the PDF for in another window
Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors
Catherine Delbaldo; Etienne Chatelut; Micheline Ré; Alain Deroussent; Sophie Séronie-Vivien; Aurore Jambu; Patrice Berthaud; Axel Le Cesne; Jean-Yves Blay; Gilles Vassal
View articletitled, Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors
Open the PDF for in another window
A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
Shinichiro Motohashi; Aki Ishikawa; Eiichi Ishikawa; Mizuto Otsuji; Toshihiko Iizasa; Hideki Hanaoka; Naomi Shimizu; Shigetoshi Horiguchi; Yoshitaka Okamoto; Shin-ichiro Fujii; Masaru Taniguchi; Takehiko Fujisawa; Toshinori Nakayama
View articletitled, A Phase I Study of <em>In vitro</em> Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
Open the PDF for in another window
A Phase I Trial of Twice-Weekly 17-Allylamino-Demethoxy-Geldanamycin in Patients with Advanced Cancer
Grzegorz S. Nowakowski; Andrea K. McCollum; Matthew M. Ames; Sumithra J. Mandrekar; Joel M. Reid; Alex A. Adjei; David O. Toft; Stephanie L. Safgren; Charles Erlichman
View articletitled, A Phase I Trial of Twice-Weekly 17-Allylamino-Demethoxy-Geldanamycin in Patients with Advanced Cancer
Open the PDF for in another window
Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
Noah M. Hahn; Sharon Marsh; William Fisher; Robert Langdon; Robin Zon; Mark Browning; Cynthia S. Johnson; Tiffany J. Scott-Horton; Lang Li; Howard L. McLeod; Christopher J. Sweeney
View articletitled, Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
Open the PDF for in another window
Pharmacokinetics and Toxicity of Weekly Docetaxel in Older Patients
Arti Hurria; Mark T. Fleming; Sharyn D. Baker; Wm. Kevin Kelly; Katie Cutchall; Katherine Panageas; James Caravelli; Henry Yeung; Mark G. Kris; Jorge Gomez; Vincent A. Miller; Gabriella D'Andrea; Howard I. Scher; Larry Norton; Clifford Hudis
View articletitled, Pharmacokinetics and Toxicity of Weekly Docetaxel in Older Patients
Open the PDF for in another window
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Michael H. Kershaw; Jennifer A. Westwood; Linda L. Parker; Gang Wang; Zelig Eshhar; Sharon A. Mavroukakis; Donald E. White; John R. Wunderlich; Silvana Canevari; Linda Rogers-Freezer; Clara C. Chen; James C. Yang; Steven A. Rosenberg; Patrick Hwu
View articletitled, A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Open the PDF for in another window
Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy
Tateki Yoshino; Hiroaki Shiina; Shinji Urakami; Nobuyuki Kikuno; Tatsuaki Yoneda; Kazushi Shigeno; Mikio Igawa
View articletitled, Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy
Open the PDF for in another window

Cancer Therapy: Preclinical

Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics
Jurjen S. Lagas; Maria L. Vlaming; Olaf van Tellingen; Els Wagenaar; Robert S. Jansen; Hilde Rosing; Jos H. Beijnen; Alfred H. Schinkel
View articletitled, Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics
Open the PDF for in another window
Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma
Enrico P. Spugnini; Irene Cardillo; Alessandra Verdina; Stefania Crispi; Silvia Saviozzi; Raffaele Calogero; Angela Nebbioso; Lucia Altucci; Giancarlo Cortese; Rossella Galati; Jeremy Chien; Viji Shridhar; Bruno Vincenzi; Gennaro Citro; Francesco Cognetti; Ada Sacchi; Alfonso Baldi
View articletitled, Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma
Open the PDF for in another window
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
Tobias Martens; Nils-Ole Schmidt; Carmen Eckerich; Regina Fillbrandt; Mark Merchant; Ralph Schwall; Manfred Westphal; Katrin Lamszus
View articletitled, A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth <em>In vivo</em>
Open the PDF for in another window
Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors
Jennifer D. Wu; Kathy Haugk; Ilsa Coleman; Lillie Woodke; Robert Vessella; Peter Nelson; R. Bruce Montgomery; Dale L. Ludwig; Stephen R. Plymate
View articletitled, Combined <em>In vivo</em> Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors
Open the PDF for in another window
Effect of Simultaneous Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in HER-2/Neu-Positive Breast Cancer
Susan Lanza-Jacoby; Randy Burd; Francis E. Rosato, Jr.; Kandace McGuire; James Little; Noel Nougbilly; Sheldon Miller
View articletitled, Effect of Simultaneous Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in HER-2/Neu-Positive Breast Cancer
Open the PDF for in another window
The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer
Kosei Hasegawa; Takafumi Nakamura; Mary Harvey; Yasuhiro Ikeda; Ann Oberg; Mariangela Figini; Silvana Canevari; Lynn C. Hartmann; Kah-Whye Peng
View articletitled, The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer
Supplementary data
Open the PDF for in another window
Gene Therapy Using Adenovirus-Mediated Full-length Anti-HER-2 Antibody for HER-2 Overexpression Cancers
Minghong Jiang; Wenfang Shi; Qi Zhang; Xinhua Wang; Minggao Guo; Zhenfu Cui; Changqin Su; Qing Yang; Yuemin Li; Jonathan Sham; Xinyuan Liu; Mengchao Wu; Qijun Qian
View articletitled, Gene Therapy Using Adenovirus-Mediated Full-length Anti-HER-2 Antibody for HER-2 Overexpression Cancers
Open the PDF for in another window
Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
Tai W. Wong; Francis Y. Lee; Chiang Yu; Feng R. Luo; Simone Oppenheimer; Hongjian Zhang; Richard A. Smykla; Harold Mastalerz; Brian E. Fink; John T. Hunt; Ashvinikumar V. Gavai; Gregory D. Vite
View articletitled, Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
Open the PDF for in another window

Cancer Susceptibility and Prevention

Grape Seed Extract Inhibits In vitro and In vivo Growth of Human Colorectal Carcinoma Cells
Manjinder Kaur; Rana P. Singh; Mallikarjuna Gu; Rajesh Agarwal; Chapla Agarwal
View articletitled, Grape Seed Extract Inhibits <em>In vitro</em> and <em>In vivo</em> Growth of Human Colorectal Carcinoma Cells
Open the PDF for in another window

Letters to the Editor

The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects
Marco Seandel; Jinru Shia; Irina Linkov; Robert G. Maki; Cristina R. Antonescu; Jakob Dupont
View articletitled, The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects
Open the PDF for in another window
Does MDR-1 G2677T/A Polymorphism Really Associate with Ovarian Cancer Response to Paclitaxel Chemotherapy?
Agnieszka H. Ludwig; Jolanta Kupryjañczyk; for the Polish Ovarian Cancer Study Group
View articletitled, Does <em>MDR-1</em> G2677T/A Polymorphism Really Associate with Ovarian Cancer Response to Paclitaxel Chemotherapy?
Open the PDF for in another window
Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
Maurice B. Loughrey; Paul M. Waring; Alex Dobrovic; George Demetri; Serge Kovalenko; Grant McArthur
View articletitled, Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
Open the PDF for in another window
Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
Eva Wardelmann; Katharina Biermann; Sabine Merkelbach-Bruse; Hans-Ulrich Schildhaus; Nadja Thomas; Reinhard Büttner; Torsten Pietsch; Thomas Heinicke; Nicola Speidel; Daniel Pink; Peter Reichardt; Peter Hohenberger
View articletitled, Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
Open the PDF for in another window

Advances in Treating Metastatic Bone Cancer

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Allan Lipton; James R. Berenson; Jean-Jacques Body; Brendan F. Boyce; Oyvind S. Bruland; Michael A. Carducci; Charles S. Cleeland; Denis R. Clohisy; Robert E. Coleman; Richard J. Cook; Theresa A. Guise; Roger N. Pearse; Trevor J. Powles; Michael J. Rogers; G. David Roodman; Matthew R. Smith; Larry J. Suva; Robert L. Vessella; Katherine N. Weilbaecher; Laura King
View articletitled, Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Open the PDF for in another window
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
Theresa A. Guise; Khalid S. Mohammad; Gregory Clines; Elizabeth G. Stebbins; Darren H. Wong; Linda S. Higgins; Robert Vessella; Eva Corey; Susan Padalecki; Larry Suva; John M. Chirgwin
View articletitled, Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
Open the PDF for in another window
Genomics and Proteomics of Bone Cancer
Aaron G. Marguiles; V. Suzanne Klimberg; Sudeepa Bhattacharrya; Dana Gaddy; Larry J. Suva
View articletitled, Genomics and Proteomics of Bone Cancer
Open the PDF for in another window
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Anke J. Roelofs; Keith Thompson; Sharon Gordon; Michael J. Rogers
View articletitled, Molecular Mechanisms of Action of Bisphosphonates: Current Status
Open the PDF for in another window
Biology of Bone Cancer Pain
Michael J. Goblirsch; Pawel P. Zwolak; Denis R. Clohisy
View articletitled, Biology of Bone Cancer Pain
Open the PDF for in another window
The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience
Charles S. Cleeland
View articletitled, The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience
Open the PDF for in another window
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Robert E. Coleman
View articletitled, Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Open the PDF for in another window
High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities?
Øyvind S. Bruland; Sten Nilsson; Darrell R. Fisher; Roy H. Larsen
View articletitled, High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter <sup>223</sup>Ra: Adjuvant or Alternative to Conventional Modalities?
Open the PDF for in another window
Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease
Jean-Jacques Body
View articletitled, Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease
Open the PDF for in another window
Multistate Analysis of Skeletal Events in Patients with Bone Metastases
Richard J. Cook; Pierre Major
View articletitled, Multistate Analysis of Skeletal Events in Patients with Bone Metastases
Open the PDF for in another window
New Potential Targets for Treating Myeloma Bone Disease
G. David Roodman
View articletitled, New Potential Targets for Treating Myeloma Bone Disease
Open the PDF for in another window
Wnt Antagonism in Multiple Myeloma: A Potential Cause of Uncoupled Bone Remodeling
Roger N. Pearse
View articletitled, Wnt Antagonism in Multiple Myeloma: A Potential Cause of Uncoupled Bone Remodeling
Open the PDF for in another window
Treatment for Myeloma Bone Disease
Howard S. Yeh; James R. Berenson
View articletitled, Treatment for Myeloma Bone Disease
Open the PDF for in another window
Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis
Robert L. Vessella; Eva Corey
View articletitled, Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis
Open the PDF for in another window
Src Inhibitors in Metastatic Bone Disease
Brendan F. Boyce; Lianping Xing; Zhenqiang Yao; Teruhito Yamashita; William C. Shakespeare; Yihan Wang; Chester A. Metcalf, III; Raji Sundaramoorthi; David C. Dalgarno; John D. Iuliucci; Tomi K. Sawyer
View articletitled, Src Inhibitors in Metastatic Bone Disease
Open the PDF for in another window
Targeting Bone Metastasis in Prostate Cancer with Endothelin Receptor Antagonists
Michael A. Carducci; Antonio Jimeno
View articletitled, Targeting Bone Metastasis in Prostate Cancer with Endothelin Receptor Antagonists
Open the PDF for in another window
Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer
Trevor Powles; Eugene McCroskey; Alexander Paterson
View articletitled, Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer
Open the PDF for in another window
Future Treatment of Bone Metastases
Allan Lipton
View articletitled, Future Treatment of Bone Metastases
Open the PDF for in another window
Skeletal Complications of Breast Cancer Therapies
Angela Hirbe; Elizabeth A. Morgan; Özge Uluçkan; Katherine Weilbaecher
View articletitled, Skeletal Complications of Breast Cancer Therapies
Open the PDF for in another window
Treatment-Related Osteoporosis in Men with Prostate Cancer
Matthew R. Smith
View articletitled, Treatment-Related Osteoporosis in Men with Prostate Cancer
Open the PDF for in another window

Advertisement

Breaking
Breast Cancer Incidence Up by Half in AAPI Women
Genentech Buys Regor’s CDK Inhibitors for $850 Million
Massive Lawsuit Against BMS Dismissed
View more recent articles
Latest News
Immune Checkpoint Inhibitors Potentially Curative for Melanoma
Next-Generation TKI Effective against ALK-Positive NSCLC
Ponsegromab Promotes Weight Gain for Cancer Cachexia
View more recent articles
Research Watch
Pan-KRAS Degraders Effectively Target KRAS-Mutant Cancers
Coagulation Factor X Directly Fuels the Growth of Prostate Cancer
The Aged Male TME Promotes Melanoma Invasion and Therapeutic Resistance
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept